C07D265/04

Bicyclic peptide-toxin conjugates specific for MT1-MMP

The present invention relates to drug conjugates comprising bicyclic peptides specific for MT1-MMP conjugated to one or more effector and/or functional groups which have utility in targeted cancer therapy.

Bicyclic peptide-toxin conjugates specific for MT1-MMP

The present invention relates to drug conjugates comprising bicyclic peptides specific for MT1-MMP conjugated to one or more effector and/or functional groups which have utility in targeted cancer therapy.

BICYCLIC PEPTIDE-TOXIN CONJUGATES SPECIFIC FOR MT1-MMP
20190134213 · 2019-05-09 ·

The present invention relates to drug conjugates comprising bicyclic peptides specific for MT1-MMP conjugated to one or more effector and/or functional groups which have utility in targeted cancer therapy.